ArticleRheumatology international2018

Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical practice: comment on "Variability of denosumab densitometric response in postmenopausal osteoporosis".

V Torrente-Segarra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.